ERLOTINIB TABLET Adverse Event: Haemoptysis
ERLOTINIB TABLET Adverse Event: Haemoptysis is one of 4,500 adverse events in the FDATracker dataset. Key details — Primary drug: ERLOTINIB TABLET; Product category: Drug; Primary reaction: Haemoptysis.
| Primary drug | ERLOTINIB TABLET |
|---|---|
| Product category | Drug |
| Primary reaction | Haemoptysis |
| All reactions | Haemoptysis; Dyspnoea; Fatigue |
| Seriousness | Serious |
| Patient outcome | Unknown |
| Patient sex | Female |
| All drugs reported | ERLOTINIB TABLET; XALATAN; CADUET; AMLODIPINE BESILATE |
| Reporter country | US |
| Reporter type | 5 |
| Report date | 20140313 |
| Report ID | 10006150 |
$299/mo
Try FDATracker →